XKRX084650
Market cap59mUSD
Dec 26, Last price
2,370.00KRW
1D
-3.46%
1Q
-17.28%
Jan 2017
-31.63%
IPO
-5.51%
Name
Labgenomics Co Ltd
Chart & Performance
P/E
—
P/S
1.20
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
7.06%
Revenues
73.13b
-49.49%
Net income
-4.67b
L
CFO
-3.83b
L
Profile
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 73,126,595 -49.49% | 144,772,746 -28.47% | 202,407,364 69.41% | ||
Cost of revenue | 56,692,268 | 59,220,086 | 84,285,647 | ||
Unusual Expense (Income) | |||||
NOPBT | 16,434,327 | 85,552,660 | 118,121,716 | ||
NOPBT Margin | 22.47% | 59.09% | 58.36% | ||
Operating Taxes | (1,839,257) | 15,467,478 | 25,276,740 | ||
Tax Rate | 18.08% | 21.40% | |||
NOPAT | 18,273,583 | 70,085,182 | 92,844,977 | ||
Net income | (4,673,918) -109.66% | 48,397,233 -42.28% | 83,854,994 96.08% | ||
Dividends | (3,317,278) | ||||
Dividend yield | 0.78% | ||||
Proceeds from repurchase of equity | 22,711,981 | (6,543,060) | |||
BB yield | -7.97% | 1.17% | |||
| Debt | |||||
Debt current | 31,208,767 | 1,033,025 | 919,829 | ||
Long-term debt | 23,527,949 | 22,223,921 | 6,521,337 | ||
Deferred revenue | |||||
Other long-term liabilities | 1,473,914 | 51,424 | 781,466 | ||
Net debt | (7,840,624) | (91,607,332) | (73,787,104) | ||
| Cash flow | |||||
Cash from operating activities | (3,826,989) | 68,954,535 | 65,361,946 | ||
CAPEX | (4,989,722) | (38,329,806) | (13,814,518) | ||
Cash from investing activities | (116,603,855) | (53,317,466) | (26,060,648) | ||
Cash from financing activities | 57,646,123 | 11,445,396 | (7,193,685) | ||
FCF | 25,436,630 | 48,418,419 | 62,084,764 | ||
| Balance | |||||
Cash | 115,390,602 | 136,971,352 | 98,998,252 | ||
Long term investments | (52,813,263) | (22,107,075) | (17,769,982) | ||
Excess cash | 58,921,010 | 107,625,640 | 71,107,902 | ||
Stockholders' equity | 207,770,172 | 194,185,668 | 137,257,999 | ||
Invested Capital | 220,342,601 | 116,573,961 | 68,887,866 | ||
ROIC | 10.85% | 75.58% | 173.49% | ||
ROCE | 5.88% | 37.96% | 84.38% | ||
| EV | |||||
Common stock shares outstanding | 73,931 | 67,736 | 67,354 | ||
Price | 3,855.00 -38.81% | 6,300.00 -24.40% | 8,333.33 32.28% | ||
Market cap | 285,005,693 -33.21% | 426,735,578 -23.97% | 561,283,128 35.27% | ||
EV | 277,512,342 | 336,307,676 | 488,202,108 | ||
EBITDA | 22,330,718 | 89,517,730 | 121,461,339 | ||
EV/EBITDA | 12.43 | 3.76 | 4.02 | ||
Interest | 4,969,491 | 573,974 | 208,032 | ||
Interest/NOPBT | 30.24% | 0.67% | 0.18% | ||